It's seems the pharmaceutical industry has encountered a BIG wake up call to join the social media bandwagon or risk being left behind. There are critical issues they face as they desire to join the conversation around regulation. Pharma companies we've spoken to - to put it simply - are scared. They want to participate, they have the money to invest and the partners to create compelling content - but are the barriers to high to dip their toe in the shallow end of the pool?
In researching pharmaceutical companies who have entered the social media arena, we stumbled across some valuable resources and prepared a case study presentation you can view below.
Firstly, allow me to share the most valuable resources I found. Mark Senak - is an expert in law and has blogged about the regulatory issues extensively in his blog Eye on FDA . Mark's blog led me to TNS Cymfony - a resource rich site full of white papers, reports and content around social media and a special report around Connecting with Patients, Overcoming Uncertainty.
We've featured 3 prominent pharmaceutical brands and case studies around their social media efforts:
1. GlaxoSmithKline: Alli Drug
2. Bayer Schering Pharma: World Contraception Day
3. Johnson & Johnson: JNJ BTW blog
Click here to view the presentation